Hsueh and colleagues reported that NVP-AUY922, an HSP90AA1 inhibitor, of which KIT is a client, regulated autophagy-mediated pathways to downregulate the expression of the KIT protein and to inhibit GIST cell growth [93]. Here, KIT is linked to gastrointestinal stromal tumor.